LOWRY SIMON C (SVP, R&D, CMO) reported 1 transaction at EMERGENT BIOSOLUTIONS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/6/2026ACC: 0002044279-26-000003
Officer· SVP, R&D, CMO
Since Mar 2026
+34.20K
Net shares
Net buyer
$89.8K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
44.83K acquired · 10.64K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.64K
Price / share
$8.44
Trade value
$89.77K
% of position
12.0%
3/5/2026
88.44K→77.80K
Total
Net shares
−10.64K
Net value
-$89.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2026 | F · Tax Withholding | −10.64K | $8.44 | $89.77K | 12.0% | 88.44K | 77.80K |
| Total | −10.64K | -$89.77K | ||||||
Derivative Transactions1
Employee Stock Option (Right to buy)
Direct
Converts to
Common Stock
44.83K shares
Shares
+44.83K
Strike price
8.99
Held after
147.83K
Exercisable
—
3/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to buy) Direct | Common Stock44.83K shares | 3/3/2026 | A · Award | +44.83K | 8.99 | — | 147.83K |